Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04087057 · ClinicalTrials.gov registry record

Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

A clinical trial, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
24
Enrollment target

NCT04087057: Completed study, sponsored by M.D. Anderson Cancer Center.

NCT04087057 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04087057 has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients with breast cancer.

Interventions

  • OTHER Medical Chart Review
  • OTHER Interview
  • BEHAVIORAL Questionnaire

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-08-23
Est. Completion 2024-04-16

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04087057

The ClinicalTrials.gov registry entry for NCT04087057 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Medical Chart Review is the first listed.

NCT04087057 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04087057 about?

NCT04087057 is a clinical study titled "Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer". This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients ...

What is the current status of trial NCT04087057?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2019-08-23. Estimated completion is 2024-04-16.

What interventions are being tested in trial NCT04087057?

The interventions under investigation include: Medical Chart Review (OTHER), Interview (OTHER), Questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT04087057?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.